BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 9746884)

  • 1. Peritoneal lavage with aprotinin in patients with severe acute pancreatitis. Effects on plasma and peritoneal levels of trypsin and leukocyte proteases and their major inhibitors.
    Berling R; Borgström A; Ohlsson K
    Int J Pancreatol; 1998 Aug; 24(1):9-17. PubMed ID: 9746884
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tissue kallikrein in severe acute pancreatitis in patients treated with high-dose intraperitoneal aprotinin.
    Bläckberg M; Berling R; Ohlsson K
    Pancreas; 1999 Nov; 19(4):325-34. PubMed ID: 10547191
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effect of peritoneal lavage and aprotinin in the treatment of severe acute pancreatitis.
    Balldin G; Borgström A; Genell S; Ohlsson K
    Res Exp Med (Berl); 1983; 183(3):203-13. PubMed ID: 6196821
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Protease-antiprotease levels and whole-blood chemiluminescence in acute peritonitis.
    Bergenfeldt M; Ohlsson K
    Gastroenterol Jpn; 1993 Oct; 28(5):687-98. PubMed ID: 8224620
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acute pancreatitis in man. A clinical and biochemical study of pathophysiology and treatment.
    Lasson A
    Scand J Gastroenterol Suppl; 1984; 99():1-57. PubMed ID: 6205440
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High-dose intraperitoneal aprotinin treatment of acute severe pancreatitis: a double-blind randomized multi-center trial.
    Berling R; Genell S; Ohlsson K
    J Gastroenterol; 1994 Aug; 29(4):479-85. PubMed ID: 7524945
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Levels of leukocyte proteases in plasma and peritoneal exudate in severe, acute pancreatitis.
    Bergenfeldt M; Berling R; Ohlsson K
    Scand J Gastroenterol; 1994 Apr; 29(4):371-5. PubMed ID: 8047815
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of high-dose intraperitoneal aprotinin treatment on complement activation and acute phase response in acute severe pancreatitis.
    Berling R; Ohlsson K
    J Gastroenterol; 1996 Oct; 31(5):702-9. PubMed ID: 8887038
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Release of neutrophil proteinase 4(3) and leukocyte elastase during phagocytosis and their interaction with proteinase inhibitors.
    Bergenfeldt M; Axelsson L; Ohlsson K
    Scand J Clin Lab Invest; 1992 Dec; 52(8):823-9. PubMed ID: 1362620
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Peritoneal lavage efficiently eliminates protease-alpha-2-macroglobulin complexes and components of the contact system from the peritoneal cavity in patients with severe acute pancreatitis.
    Aasen AO; Ruud TE; Roeise O; Bouma BN; Stadaas JO
    Eur Surg Res; 1989; 21(1):1-10. PubMed ID: 2469582
    [TBL] [Abstract][Full Text] [Related]  

  • 11. On the role of the pancreatic secretory trypsin inhibitor as an inactivator of trypsin-alpha 2-macroglobulin complexes in acute pancreatitis.
    Balldin G; Borgström A; Marks WH; Ohlsson K
    Hoppe Seylers Z Physiol Chem; 1984 Jul; 365(7):751-6. PubMed ID: 6207093
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effective intraperitoneal antiprotease therapy for taurocholate-induced pancreatitis in rats.
    Wilson C; Imrie CW
    Br J Surg; 1990 Nov; 77(11):1252-5. PubMed ID: 1701328
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tracheobronchial aspirate fluid neutrophil lipocalin, elastase- and neutrophil protease-4-alpha1-antitrypsin complexes, protease inhibitors and free proteolytic activity in respiratory distress syndrome.
    Sveger T; Ohlsson K; Polberger S; Noack G; Mörse H; Laurin S
    Acta Paediatr; 2002; 91(9):934-7. PubMed ID: 12412868
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Intra-peritoneal aprotinin therapy for acute pancreatitis. Preliminary pharmacodynamic studies.
    Larvin M; Mayer AD; McMahon MJ; Müller-Esterl W; Fritz H
    Biol Chem Hoppe Seyler; 1988 May; 369 Suppl():149-52. PubMed ID: 2462429
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Demonstration of pancreatic protease-antiprotease complexes in the peritoneal fluid of patients with acute pancreatitis.
    Balldin G; Ohlsson K
    Surgery; 1979 Apr; 85(4):451-6. PubMed ID: 432805
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification, origins and the diurnal role of the principal serine protease inhibitors in human tear fluid.
    Sathe S; Sakata M; Beaton AR; Sack RA
    Curr Eye Res; 1998 Apr; 17(4):348-62. PubMed ID: 9561826
    [TBL] [Abstract][Full Text] [Related]  

  • 17. On the potential role of trypsin and trypsin inhibitors in acute pancreatitis.
    Lasson A; Ohlsson K
    Adv Exp Med Biol; 1984; 167():477-87. PubMed ID: 6201050
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Protease inhibitors in acute human pancreatitis. Correlation between biochemical changes and clinical course.
    Lasson A; Ohlsson K
    Scand J Gastroenterol; 1984 Sep; 19(6):779-86. PubMed ID: 6083596
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Serial alterations in the forms of immunoreactive pancreatic cationic trypsin in plasma from patients with acute pancreatitis.
    Durie PR; Gaskin KJ; Ogilvie JE; Smith CR; Forstner GG; Largman C
    J Pediatr Gastroenterol Nutr; 1985 Apr; 4(2):199-207. PubMed ID: 2580962
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Human cationic, pancreatic elastase in acute pancreatitis.
    Håkansson HO; Borgström A; Ohlsson K
    Scand J Clin Lab Invest; 1993 Feb; 53(1):17-24. PubMed ID: 7680823
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.